Serological Evidence of Tick-Borne Encephalitis Virus Infection in Rodents Captured at Four Sites in Switzerland by Burri, Caroline et al.
SHORT COMMUNICATION
Serological Evidence of Tick-Borne Encephalitis Virus Infection in
Rodents Captured at Four Sites in Switzerland
CAROLINE BURRI,1 MISA KORVA,2 VIKTORIA BASTIC,1 NATASˇA KNAP,2
TATJANA AVSˇICˇ-ZˇUPANC,2 AND LISE GERN1,3
J. Med. Entomol. 49(2): 436Ð439 (2012); DOI: http://dx.doi.org/10.1603/ME11084
ABSTRACT In a previous study, the presence of tick-borne encephalitis virus (TBEV) in questing
Ixodes ricinus L. ticks and in Þeld derived ticks that engorged on small mammals (n  9,986) was
investigated at four sites located in a TBE area in Switzerland. Two of these sites were already
recognized as TBE foci (Thun and Belp) and the screening of ticks revealed the presence of TBEV
in ticks at a third site, Kiesen, but not at the fourth one, Trimstein. The aim here was to test another
approach to detect TBE endemic areas. Sera from 333 small mammals (Apodemus flavicollis, A.
sylvaticus,Myodesglareolus)captured in2006and2007at the four siteswereexamined for thepresence
of antibodies against TBEV using immunoßuorescence and avidity tests. Overall the prevalence of
antibodies against TBEV in rodents reached 3.6% (12/333). At two sites known as TBE foci, Thun and
Belp, anti-TBEVantibodieswere detected in 9.9% (9/91) and 1.6% (1/63) of rodent sera, respectively.
At the third site, Kiesen, recently identiÞed as a TBE focus by the detection of TBEV in ticks,
anti-TBEV antibodies were detected in 1.8% (2/113) of rodent sera. Finally, at Trimstein, none of the
examined rodent sera had antibodies against TBEV (0/66). This study shows another approach to
detect TBE foci by testing antibodies in small mammal sera that is less time-consuming and less
expensive than molecular tools.
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Tick-borne encephalitis virus (TBEV) is a ßavivirus
that accidentally infects human. In Europe, TBEV is
transmitted by a tick bite and is maintained in a zoo-
notic cycle between Ixodes ricinus L. and vertebrate
hosts. Ticks may become infected while feeding on a
host during the viraemic phase, in so far as level of
viraemia is sufÞciently high enough (Kunz 1992). As
infected hosts rapidly develop speciÞc antibodies and
become immune for life (Korenberg 1976) all verte-
brates do not act as reservoir hosts (Charrel et al.
2004). However, the viraemic phase is not a necessary
condition for TBEV transmission to ticks (Labuda et
al. 1993a). Indeed Labuda et al. (1993a) showed a
TBEV transmission when ticks were feeding on non-
viraemic hosts. This nonviraemic transmission occurs
from TBEV infected to uninfected ticks feeding si-
multaneously and is called cofeeding transmission
(Labuda et al. 1993b). Later Labuda et al. (1997) even
showed that cofeeding transmission occurs on im-
mune rodent hosts. Thus, small mammals contribute
mostly to the TBEV maintenance because they sup-
port cofeeding transmission even if they are immune
(Labuda et al. 1997) and because of their high repro-
duction rate that decreases the impact of immuniza-
tion (Shilova 1960 cited in Korenberg 1976).
Previously,we investigated thepresenceofTBEVin
questing I. ricinus ticks and in ticks that engorged on
rodents (n 9,986) at four sites located in Switzerland
(Burri et al. 2011). Among these sites, two of them
were known as TBE foci (Thun and Belp), meaning
that at least threehumancases fromeach sitehadbeen
reported to the Federal OfÞce of Public Health.
Screening for the presence of the virus in ticks by
real-time polymerase chain reaction (RT-PCR) al-
lowed the detection of TBEV at three out of four sites
(Thun, Belp, and Kiesen) but not at Trimstein. In the
current study, our purpose was to use another ap-
proach to detect TBE foci by testing small mammal
sera for antibodies against TBEV.
Materials and Methods
Rodents were trapped once a month during 2006
and 2007 using 50 traps that were set at four sites
presenting similar beech grove mesophytic lowland
vegetation: Thun (46 43N, 7 36 E, 642 m above sea
level), Belp (46 52N, 7 30E, 687mabove sea level),
Kiesen (46 48N, 7 34E, 566 m above sea level) and
Trimstein (46 53 N, 7 34 E, 620 m above sea level)
(Burri et al. 2011). Rodents were brought to the lab-
oratory.After tickdrop-off, rodentswereanesthetized
intramuscularly with 0.03 ml of Xylasol. (GRAEUB,
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Bern, Switzerland) (0.02 ml) and Ketasol-100
(GRAEUB) (0.01 ml) and blood was obtained from
the retro-orbital sinus using Pasteur pipettes (1.1 mm
diameter). Blood samples were centrifuged twice for
10 min at 0.8 rcf (relative centrifugal force) and sera
were stored at 20C until processed.
Sera were screened for the presence of TBEV an-
tibodies using a homemade indirect immunoßuores-
cence assay (IFA).TBEV(strain: Ljubljana I,U27494)
was inoculated on Vero E6 cell lines and incubated at
37C and 5% CO2. After 7 d, when characteristic cy-
topathic effect was noted, cells were centrifuged for
10 min at 720 rcf and 4C. Cells were resuspended in
3 ml NaCl with 5% fetal bovine serum (GIBCO, In-
vitrogen, cat. no. 16415) and 7 l of suspension were
put on slides (Biomedicals, cat. no. 096041505), dried,
Þxed with acetone, and stored at 20C. Before IFA,
slides were allowed to dry for 10 min. Seven microli-
ters of rodent sera diluted 1:10 were used for IFA.
After 30 min incubation in a moist chamber at room
temperature, slides were washed in phosphate buffer
saline (PBS; pH 7.4) for 15 min. The antimouse IgG
conjugate (A 7506; Sigma, St. Louis, MO) was used at
a 1:128 dilution and slideswere processed as described
above, and examined under a ßuorescent microscope
(Nikon, eclipse 80i, 400). Positive and negative con-
trols consisted in one rodent serum that was previ-
ously tested positive and PBS (pH 7.4), respectively.
Sera from seropositive rodents were further diluted
up to 1:2560 to establish the antibody titers and an IFA
avidity assaywas performed. IFA assaywas performed
in duplicate. Conditions were the same as described
above. After incubation with antimouse IgG conju-
gate, one set of slideswaswashed in PBS and the other
set with PBS containing 8 M urea. Slides were incu-
bated inPBSwithurea for 5min and thenwashedwith
distilled water. The avidity of IgG was calculated as a
ratio of the titers obtained from slides washed in PBS
and from slides treated with PBS containing urea. An
antibody ratio above 32 indicates low IgG avidity and,
therefore, an early periodof infection (less than 1mo)
whereas a ratio of four or less indicates high IgG
avidity and therefore an infection older than 1 mo.
After 2 mo of infection, no difference is observed
between antibody titers of urea-treated and non-
treated specimens.
Sera with antibodies against TBEV were tested for
viraemia by amplifying RNA. RNA was isolated using
TRIzol (600 l) (Invitrogen Life Technologies, Basel,
Switzerland) (Chomczynski and Sacchi 1987) and
samples were analyzed by RT-PCR (Schwaiger and
Cassinotti 2003) as described in Burri et al. (2011). A
FischerÕs exact testwasused for statistical analyses and
a P value 0.05 was considered as signiÞcant.
Results
Overall, 559 rodents were captured: 278 M. glareo-
lus, 161A. sylvaticus, 118A. flavicollis, and 2Apodemus
spp. Trapping was more successful in 2007 (0.2 ro-
dents/trap/night) comparedwith 2006 (0.06 rodents/
trap/night) (Burri et al. 2011). Details on the number
of collected rodents at each site are shown in Table 1.
We analyzed 333 sera from three small mammal spe-
cies: 152 M. glareolus, 104 A. sylvaticus, and 77 A.
flavicollis captured at the four sites in 2006 (n  74)
and 2007 (n 259). Overall, antibodies against TBEV
were detected in 3.6% (12/333) of rodent sera, 6.8%
(5/74) in 2006, and 2.7% (7/259) in 2007 (Fisher exact
test; P  0.05). Anti-TBEV antibodies were detected
in sera from rodents captured at three sites: Thun,
Belp, and Kiesen whereas sera from rodents captured
at Trimstein did not show any antibodies (Table 2).
The highest prevalence was observed at Thun (9.9%,
9/91), followed by Kiesen (1.8%, 2/113), Belp (1.6%,
1/63), and Trimstein (0%, 0/66) (Fisher exact test:
Thun/Kiesen, P  0.01; Thun/Belp, P  0.04; Thun/
Trimstein, P  0.01) (Table 2).
Among the 12 rodents with anti-TBEV antibodies,
eight belonged to M. glareolus, three to A. sylvaticus,
and one to A. flavicollis (Fisher exact test, P  0.05)
(Table 3). TwoM. glareolus (one fromThun, one from
Kiesen) had no tickwhereas the remaining 10 rodents
harbored ticks when they were captured. However,
only one A. flavicollis male (Th37) carried TBEV in-
fected ticks (Burri et al. 2011). This individual showed
a recent TBEV infection as determined by IgG IFA
avidity assay (Table 3). Therefore, we tested for vi-
raemia in rodent sera presenting antibodies against
TBEV. Screeningof the sera byRT-PCRdidnot reveal
the presence of viral RNA in the 12 analyzed serum
samples.
Discussion
This study showed that serological investigation in
the rodent population is another approach to detect
presence of TBEV in endemic sites. The analysis of
only 333 sera from rodents captured in 2006Ð2007
allowed us to detect the presence of anti-TBEV anti-
bodies at threeoutof four(Thun,Belp,Kiesen,butnot
at Trimstein) sites in Switzerland whereas in a previ-
ous study, the screening of 9,986 ticks by RT-PCR
(Thun: n  2,001; Belp: n  2,117; Kiesen: n  4,230;
Table 1. Number of rodents according to species per 100 traps
per site and per night in 2006 and 2007
Sites
A. flavicollis A. sylvaticus M. glareolus
2006 2007 2006 2007 2006 2007
Thun 0.5 3.3 3.0 5.2 3.0 8.3
Belp 0.5 2.0 0.5 6.8 1.3 7.3
Kiesen 1.7 5.3 1.7 2.3 6.9 19.0
Trimstein 3.1 5.5 0.6 8.8 1.4 4.0
Table 2. Prevalence of anti-TBEV antibodies in rodents cap-
tured at the four study sites using IFA test
Sites Nb positive/tested sera %
Thun 9/91 9.9
Belp 1/63 1.6
Kiesen 2/113 1.8
Trimstein 0/66 0
Total 12/333 3.6
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Trimstein: n  1,638) was necessary to evaluate the
presence/absence of TBEV at the four sites (Burri et
al. 2011).
A small proportion of rodents displayed anti-TBEV
antibodies, ranging from 1.6 to 9.9%, but these results
are consistent with results from Kozuch et al. (1967)
and Bakhvalova et al. (2006) who reported antibody
prevalence of 4Ð11% and 2.6Ð10.2%, respectively. In-
terestingly, although more rodents were captured in
2007, seroprevalence in rodentwas lower than in 2006.
A greater proportion of young individuals in the ro-
dent population could have contributed to dilute the
seroprevalence. Unfortunately, we do not have any
data on the population structure. Alternatively, at
most sites, the low infestation by immature ticks on
rodents in 2007 (Burri et al. 2011) may explain the
lower prevalence of antibodies in rodents this year.
Thun was the site where the prevalence of anti-
TBEV antibodies in rodent sera was the highest. In
1977 already, Matile (1982) reported the presence of
antibodies against TBEV in four small mammals at this
same study site. This observation shows the stability of
this focus. At Belp, TBEV in questing I. ricinus ticks
(de Marval 1994, Casati et al. 2006, Burri et al. 2011)
and anti-TBEV antibodies in rodent sera were de-
tected conÞrming the presence of the virus at this site.
Kiesen andTrimsteinwerenot recognized asTBE foci
by the Federal OfÞce of Public Health http://www.
bag.admin.ch/themen/medizin/00682/00684/01069/
index.html?lang fr) becausenohumancasehas ever
been reported at these sites. However, Kiesen should
now be considered as a TBE focus because TBEV was
recently detected in questing ticks (Burri et al. 2011)
and because of the detection of anti-TBEV antibodies
in rodents. Trimstein is the only site where TBEV was
not detected in ticks (Burri et al. 2011) and where
anti-TBEV antibodies were not observed in rodents.
Current results do not allow to deÞnitively conclude
that TBEV was absent at Trimstein because no signif-
icant difference in seroprevalence between any of the
sites, except Thun was found. Further studies are
needed to conÞrm the absence of the circulation of
TBEV at this site although the results on ticks at this
site (Burri et al. 2011) certainly support this conclu-
sion.
No viral RNA was detected in the seropositive sam-
ples. It should be noted that the absence of viraemia
could be because of the fact that rodents blood was
taken after all ticks dropped off (after 7 d) whereas
viraemia lasts only 2Ð3 d (Kozuch et al. 1981).
One A. flavicollis that showed a recent TBEV in-
fection by IgG IFA avidity assay was infested by in-
fected larvae (11.9%) and uninfected nymphs (n 5)
when it was captured (Burri et al. 2011). As Labuda et
al. (1993a) showed that A. flavicollis does not develop
a viraemia, or does so at a very low level, many alter-
native explanations for the high prevalence of infec-
tion detected in larvae can be given. The presence of
TBEV in larvae might be explained by transovarial
transmission (Danielova´ and Holubova´ 1991). How-
ever, the prevalence of TBEV in larvae feeding on this
Apodemus mouse was much higher (11.9%) (Burri et
al. 2011) than the efÞciency of transovarial transmis-
sion(0.2Ð0.8%)describedbyDanielova´ andHolubova´
(1991) suggesting anotherwayof transmission.There-
forecofeeding transmissionofTBEVamongcofeeding
larvae (some of them having been transovarially in-
fected)might be another explanation andas thismode
of infection is not absolute (Labuda et al. 1993a), it
could explain why the nymphs that were cofeeding
with larvae when the animal was captured were un-
infected.
The screening of rodent sera for anti-TBEV anti-
bodies revealed to be an appropriate approach to
localize the presence of TBEV at sites where TBEV
was also detected in ticks (Burri et al. 2011). One
advantage of this approach is that it is less time-con-
suming and less expensive than molecular tools. This
IFAavidityassaywasnot testedagainst cross reactivity
with other ßaviviruses such as West Nile virus and
Louping-ill virus in Europe. However as West Nile
virus is a mosquito borne virus and rodents are not
involved in the enzootic cycle and as the Louping-ill
virus it is not persistent in small mammals in nature
(Gilbert et al. 2000) the risk of cross reactivity is low,
at least in the studied sites. Thus, rodents could be
used as sentinels to detect TBEVby testing anti-TBEV
antibodies in areas suspected to be endemic for TBE.
Other animals such as roe deer and dogs were used as
sentinels to detect TBEV areas (Gerth et al. 1995,
Lindheetal. 2009).However, smallmammals aremore
appropriate because of their low home range allowing
a more precise localization of a TBEV focus.
Table 3. IFA antibody titers and avidity ratio in rodent sera with anti-TBEV antibodies to predict a recent or a past infection in rodents
Sample
ID
Species Sex End titre Titre with urea Avidity ratio Infection
Thun 9 M. glareolus Male 1:80 1:40 2 High Old
Thun 10 M. glareolus Male 1:320 1 320 Low New
Thun 12 M. glareolus Female 1:640 1:320 2 High Old
Thun 23 M. glareolus Female 1:640 1:40 16 Equivocal ?
Thun 35 M. glareolus Male 1:40 1 40 Low New
Thun 37 A. flavicollis Male 1:40 1 40 Low New
Thun 45 M. glareolus Male 1:80 1:10 8 High Old
Thun 51 A. sylvaticus Male 1:40 1:40 1 High Old
Thun 58 M. glareolus Male 1:640 1:80 8 High Old
Kiesen 26 A. sylvaticus Female 1:80 1 80 Low New
Kiesen 135 M. glareolus Female 1:80 1 80 Low New
Belp 49 A. sylvaticus Female 1:160 1 160 Low New
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